MoneyWorks4Me

Medicamen Biotech informs about board meeting

03 Jun 2016 Evaluate

Medicamen Biotech has informed that a meeting of the Board of Directors of the Company will be held on June 10, 2016, to consider the Preferential Allotment of Equity Shares & Convertible Warrants into Equity Shares.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..